CTi Biopharma Corp (NASDAQ:CTIC)

4.79
Delayed Data
As of May 23
 +0.01 / +0.21%
Today’s Change
2.45
Today|||52-Week Range
4.99
+78.73%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for CTi Biopharma Corp have a median target of 7.00, with a high estimate of 10.00 and a low estimate of 5.00. The median estimate represents a +46.14% increase from the last price of 4.79.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in CTi Biopharma Corp. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.24
Sales
$900.0K
Reporting Date
Aug 02

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -200.00%
 
 
 
 
 
 
Growthannually 28.43%
 
 
 
 
 
 

Sales

Growthquarterly -91.41%
 
 
 
 
 
 
Growthannually -47.43%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.